While GLP-one receptor agonists are thrilling, Pedersen hopes to at some point see additional new courses of drugs “making sure that we will help Individuals patients who just don’t tolerate the GLP-1.”Normal human GLP-1 breaks down speedily in the body, and its effects are limited-lived. In the nineties drug companies started seeking to crea